Press Releases
Current and archived press releases appear below. Contact John Huber at (800) 747-2820 or huber@aamds.org for comments and additional information.
Wednesday, August 31, 2011
The Aplastic Anemia and MDS International Foundation
has awarded scholarships ranging from $500 to $2000 to students across the United
States who have been impacted by bone marrow failure disease.
Eighteen students received an AA&MDSIF Harry
Carson Scholarship in August. Established by the former New York Giants...
Monday, May 30, 2011
FOR IMMEDIATE RELEASE:
The Aplastic Anemia &
MDS International Foundation is pleased to announce the recipients of its 2010-2012
Research Grants, awarded as two-year grants of $30,000 per year.
Gregory A. Abel, MD, of Dana-Farber Cancer Institute, Boston,
Massachusetts for his research project, Developing a...
Monday, May 30, 2011
The Aplastic Anemia &
MDS International Foundation is pleased to announce that all four two-year
research grants awarded in 2008 have been successfully concluded and summary
research reports have been received.
“This most recently
concluded group of research studies funded by AA&MDSIF has made a real...
Wednesday, December 1, 2010
According to the
Aplastic Anemia & MDS International Foundation (AA&MDSIF), approximately 50 people are diagnosed every
day with a bone marrow failure disease. Virtually all of them will need blood
transfusions and many will be seeking a bone marrow donor match.
Life-threatening bone
marrow failure diseases...
Wednesday, March 18, 2009
Testimony before the Public Witness Hearing March 18, 2009 House Appropriations Subcommittee on Labor-Health and Human Services-EducationbyNeil Horikoshi, Chairman of the BoardAplastic Anemia & MDS International Foundation
Thank you, Mr. Chairman and members of the subcommittee, for giving me the opportunity to...
Monday, October 27, 2008
Washington D.C. – (October 24, 2008) – The Aplastic Anemia & MDS International Foundation is pleased to inform patients that the European Committee for Medicinal Products for Human Use (CHMP) has awarded Vidaza (azacitidine) a positive opinion for the treatment of myelodysplastic syndromes (MDS) patients who are...
Friday, September 26, 2008
The Aplastic Anemia & MDS International Foundation (AA&MDSIF) applauds the Prix Galien USA Awards committee for giving top honors to pharmaceutical companies Celgene and Alexion for their revolutionary remedies that treat the symptoms of rare bone marrow failure diseases, myelodysplastic syndromes (MDS) and...
Online Learning Center
Action Center
Find out how you can further research and treatment. Act now!
This site complies with the HONcode standard for trustworthy health information: verify here.
